GSK’s Shingles Vaccine Linked to Lower Risk of Heart Disease in Major Study
Product·2 articles across 2 outlets
Story updated Rewritten when the story materially grows; the wire is checked every 15 minutesAbout this data
GSK Plc’s shingles vaccine was linked to a lower risk of cardiovascular disease in a major study, potentially boosting the chances of wider usage for the drugmaker’s top-selling product.
Oxford researchers call shingles shot first vaccine protecting both heart and brain. Lower heart disease risk follows study showing reduced dementia risk.
GSK
Sources
Every quote below is verbatim from the article it is attributed to.
SourceReports the news
“GSK Plc’s shingles vaccine was linked to a lower risk of cardiovascular disease in a major study, potentially boosting the chances of wider usage for the drugmaker’s top-selling product.”
Bloomberg — GSK’s Shingles Vaccine Linked to Lower Risk of Heart Disease“Oxford researchers call shingles shot first vaccine protecting both heart and brain.”
stat news — Newer shingles vaccine linked to lower heart disease risk, ‘natural experiment’ shows